Clinical trial Recruiting at 1 site Observational Ages 28 Weeks to 34 Weeks

Exploring how maternal stress affects breastmilk and preterm infant development

Official title: Maternal Stress, Human Milk Composition, and Neurodevelopmental and Feeding Outcomes

Run by University of Minnesota · NCT05537454 · Data updated 2026-11-12

This study looks at how stress in mothers affects the quality of their breastmilk and the development of their preterm babies.

Quick facts

Study typeObservational
Ages28 Weeks to 34 Weeks
SexAll
Enrollment120 (estimated)
SponsorUniversity of Minnesota
Academic / other
Locations1 site (Minneapolis, Minnesota)
StatusRecruiting
StartedDecember 9, 2022
Main results expectedJuly 31, 2027
Study endsJuly 31, 2030
Registry record updatedSeptember 14, 2026
Trial IDNCT05537454 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include mothers aged 18 to 45 with medically stable preterm infants born between 28 and 34 weeks of gestation.

Probably not a fit

Patients who may not benefit include those with major congenital anomalies or significant health issues affecting infant feeding and growth.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study investigates the relationship between maternal stress, the composition of breastmilk, and neurodevelopmental outcomes in preterm infants. Mothers of infants born between 28 to 34 weeks of gestation will be recruited to assess how variations in maternal stress influence milk volume and quality, as well as the cognitive development of their infants at NICU discharge and at four months corrected age. The study will also involve collecting and analyzing maternal milk and infant fecal samples to explore the impact of maternal stress on gut microbiome and metabolomic profiles. The overarching goal is to enhance neurodevelopmental health for preterm infants by strengthening the mother-milk-infant connection.

Why it matters

Potential benefit: If successful, this study could lead to improved feeding strategies and neurodevelopmental outcomes for preterm infants.

How similar studies have gone: While the specific approach of this study is novel, previous research has indicated that maternal factors can significantly influence infant health outcomes.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* preterm infant born between 25 0/7 and 34 6/7 weeks' gestation that are medically stable for study procedures
* mother of preterm infant meeting criteria and a) 18 to 45 years of age at the time of delivery

Exclusion Criteria:

* infants: major congenital anomalies, anticipated death, positive blood culture at birth, hypoxic ischemic encephalopathy, grade IV intraventricular hemorrhage, or plan to transfer care before discharge (35-37 weeks postmenstrual age).
* mothers: known congenital metabolic, endocrine disease or congenital illness affecting infant feeding/growth

Where it's running

  • University of Minnesota
    Minneapolis, Minnesota, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.